Management of Chronic Heart Failure: Biomarkers, Monitors, and Disease Management Programs
Background: The management of patients with heart failure has been evolving given the complex nature of the disease and the increasing number of patients. Findings: Biomarkers, and in particular the natriuretic peptides, have been studied to assist with diagnosis, chronic management, and prognosis i...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Ubiquity Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2bffb01905454d919142cfc528640ae1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Background: The management of patients with heart failure has been evolving given the complex nature of the disease and the increasing number of patients. Findings: Biomarkers, and in particular the natriuretic peptides, have been studied to assist with diagnosis, chronic management, and prognosis in patients with heart failure. Several new biomarkers are emerging and may be used individually or in combination with the natriuretic peptides. The use of cardiac monitoring devices and disease management programs is being established to assist in the care of patients with chronic heart failure. Interventions using phone calls, telemedicine devices, intracardiac pressure monitors, and implantable cardioverter defibrillators have been investigated. Conclusions: The combination of biomarkers, monitoring devices, and disease management programs shows promise for improving care in this challenging patient population. |
|---|